Skip to main content

Study M883

Study name

Zhao HY 2022

Title

A pilot exploration of multi-omics research of gut microbiome in major depressive disorders

Overall design

The aim of this study was to explore the connection between the microbiome metagenomics, immunology, metabolomics, and brain structure in major depressive disorders (MDD). The data of metabolomic, metagenomics, inflammatory factors, and MRI scanning are collected from the two groups including drug-naive MDD patients (MDD group, n =24) and healthy controls (control group, n = 26). Blood samples were used for LC-MS-based metabolomic analysis.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Depression; Depression;

Criteria for depression

DSM-5 diagnosed MDD, HAMD-17 > 17

Sample size

50

Tissue

Peripheral; Blood; Blood;

Platform

MS-based; LC-MS: ExionLC AD system (SCIEX) coupled with a QTRAP 6500+ mass spectrometer (SCIEX);

PMID

35013099

DOI

10.1038/s41398-021-01769-x

Citation

Zhao H, Jin K, Jiang C, et al. A pilot exploration of multi-omics research of gut microbiome in major depressive disorders. Transl Psychiatry. 2022 Jan 10;12(1):8.

Metabolite

Linoleic acid;

Cholic acid;

Xanthine;

Taurine;

Niacinamide;

Dihydroxyacetone phosphate;

L-Malic acid;

Adenosine monophosphate;

Glycerophosphocholine;

Glycocholic acid;

Phosphoenolpyruvic acid;

ADP;

LysoPE(18:0);

Spermidine;

Cytidine monophosphate;

O-Phosphoethanolamine;

10E,12Z-Octadecadienoic acid;

gamma-Glutamylglutamic acid;

Galactinol;

Vitamin A;

All-trans-13,14-dihydroretinol;

Hypogeic acid;

(2R,3R)-2-Aminooctadecane-1,3-diol;

D-Mannose 6-phosphoate;

D-malic acid;

3'-aenylic acid;

Picolinamide;

N'-feruloyl putrescine;

Niflumic acid;

Carnitine C4;

5-Hydroxyindole-2-carboxylic acid;

Aspartyl-Glutamate;

Lysine butyrate;